Project Grant R03DE032387
- This $322,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support secondary data analysis from the CariesAway study to advance the implementation of school-based oral health programs using silver diamine fluoride (SDF). The research aims to explore the longitudinal caries arrest capabilities of school-based SDF applications, estimate surface-level caries risk...
- The University of Kansas Center for Research Inc. was awarded a $467,008 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), to develop a novel non-invasive treatment for dental caries in children and patients with special needs. The project aims to create a biomimetic peptide-polymer interface that works synergistically with silver diamine fluoride (SDF) to arrest caries progression and...
- This federal Project Grant award of $693,179 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports a multistage mixed methods study to determine the impact of Medicaid reimbursement policies on the use of silver diamine fluoride (SDF) treatment and downstream oral health outcomes for Medicaid-enrolled children. Specifically, the study will (1) assess the impact of Medicaid SDF...
- This $728,647 Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a study to construct a statewide dataset on Medicaid Accountable Care Organizations (ACOs) and children's oral health in Massachusetts. The study aims to 1) identify and describe children and primary care clinicians enrolled in Medicaid ACOs, and 2) compare rates of fluoride varnish applications among primary...
- This federal Project Grant award of $297,711.00, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop and test zinc tetraammine difluoride (ZAF) as a non-invasive, aesthetic, and cost-effective alternative to traditional dental caries management strategies. The objective is to determine the mineral loading efficacy of ZAF agents in human dentin, with the goal of providing ZAF as a...
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $639,248 Project Grant to the University of Florida to assess the marginal associations between dental caries and periodontal diseases, and their determinants, in cross-sectional studies. The research will develop statistical methodologies to address the challenge of "informative cluster size" in analyzing correlated dental...
- This Project Grant award of $965,145, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program, aims to examine disparities in oropharyngeal cancer (OPC) outcomes among Medicaid-enrolled adults. The key objectives are to: Characterize differences in early-stage diagnosis and 5-year survival rates for OPCs based on race, ethnicity, sex, and rurality using the SEER-Medicaid dataset. Assess the impact of...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $460,885 to The Trustees of the University of Pennsylvania to investigate how the interaction between the fungus Candida albicans and the bacteria Streptococcus mutans leads to the initiation and progression of severe early-childhood caries (S-ECC). The research aims to understand how this interkingdom microbial...
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded a $270,594 Project Grant to Greenmark Biomedical Inc. on Sep 1, 2025. The grant supports the development of nano-fluorapatite particles to directly fill subsurface enamel pores, with the goal of halting the progression of non-cavitated carious lesions without requiring multiple remineralization treatments. Preliminary data demonstrates the ability of...
- The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), awarded a $155,500 Project Grant to The University of Iowa. The grant funds a study to identify the causal effects of preventive dental services, including comprehensive oral exams, prophylaxis, fluoride application, and dental sealants, on academic achievement among children enrolled in Medicaid in Iowa. The study aims to determine the ages at...
SURVIVAL ANALYSIS OF TEETH TREATED WITH SDF TO ARREST CARIES IN ADULTS - PROJECT SUMMARY / ABSTRACT DENTAL CARIES IS A PREVENTABLE DISEASE, HOWEVER, IT STILL AFFECTS LARGE NUMBERS OF PEOPLE GLOBALLY AND IN THE US. THE GLOBAL BURDEN OF DISEASE 2017 STUDY SHOWED AN ESTIMATED 2.3 BILLION PEOPLE HAD DENTAL CARIES OF PERMANENT TEETH, AND OF ALL EVALUATED CONDITIONS, ORAL DISORDERS RANKED FIRST IN AGE-STANDARDIZED PREVALENCE IN MALES AND FEMALES. DATA FROM THE US NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2011-2016 CYCLE FOUND THAT 1 IN 4 ADULTS AGES 20 TO 64 YEARS HAVE UNTREATED TOOTH DECAY. APPROXIMATELY EQUAL NUMBERS OF MALES (28.0%) AND FEMALES (24.3%) HAD UNTREATED CARIES. VARIATION WAS OBSERVED ACCORDING TO RACE AND ETHNICITY AND HIGHER RATES WERE OBSERVED FOR NON-HISPANIC BLACKS (40.2%) AND MEXICAN AMERICAN (37.1%) COMPARED TO NON-HISPANIC WHITES (22.2%). ADDITIONAL VARIATION WAS NOTED ACCORDING TO POVERTY STATUS, WITH 45.3% OF ADULTS WITH INCOME LESS THAN 100% FEDERAL POVERTY LEVEL HAVING UNTREATED TOOTH DECAY, COMPARED TO ONLY 17.7% OF INDIVIDUALS WITH GREATER THAN 200% FEDERAL POVERTY LEVEL STATUS. FURTHERMORE, ACCORDING TO A SURVEY CONDUCTED BY THE AMERICAN DENTAL ASSOCIATION IN 2015, 59% OF ADULTS INDICATED THAT THEY FORGO DENTAL CARE DUE TO COST, 22% BECAUSE THEY ARE AFRAID OF THE DENTIST AND 19% BECAUSE THEY CANNOT FIND A CONVENIENT LOCATION OR APPOINTMENT TIME. TAKEN TOGETHER, THESE STATISTICS UNDERSCORE THE IMPORTANCE OF DENTAL CARIES TREATMENT THAT IS EASY TO ACCESS, AFFORDABLE AND EFFECTIVE. SILVER DIAMINE FLUORIDE (SDF) HAS BEEN USED IN MANY PARTS OF THE WORLD TO ARREST DENTAL CARIES, HOWEVER, MULTIPLE SYSTEMATIC REVIEWS USING DATA FROM RANDOMIZED CONTROLLED TRIALS HAVE CONCLUDED THERE IS EVIDENCE TO SUPPORT CARIOUS LESION ARREST IN PRIMARY TEETH IN CHILDREN, BUT THERE IS INSUFFICIENT EVIDENCE TO DRAW CONCLUSION FOR EFFECTIVENESS ON PERMANENT TEETH IN CHILDREN OR ON CORONAL SURFACES OF TEETH IN ADULTS. GIVEN THAT LARGE-SCALE PROSPECTIVE STUDIES ON ADULT CARIES OUTCOMES ARE COSTLY AND LENGTHY, AND THAT DENTAL CARIES IS A MULTI-FACTORIAL DISEASE PROCESS, IT IS IMPORTANT FOR STUDIES TO COLLECT DATA ON KEY FACTORS SUCH AS MEDICAL COMORBIDITIES, MEDICATION USE, AND ACCESS TO PREVENTIVE DENTAL SERVICES. OUR PROPOSED USE OF EXISTING DATA THUS REPRESENTS A HIGHLY EFFICIENT APPROACH TO CONDUCTING ROBUST ANALYSES ON THE EFFECTIVENESS OF SDF TO ARREST CARIOUS LESIONS IN ADULTS AND PREVENT THE NEED FOR MORE INVASIVE TREATMENT. THUS, OUR PRIMARY AIM IS TO DETERMINE WHETHER TEETH TREATED WITH SDF TO ARREST A CARIOUS LESION REQUIRED SUBSEQUENT CARIES-RELATED EXTRACTION, ROOT CANAL THERAPY OR DIRECT/INDIRECT RESTORATION DURING THE 1-5 YEAR FOLLOW-UP PERIOD. OUR SECONDARY AIM IS TO DETERMINE WHETHER 2 OR MORE APPLICATIONS OF SDF ARE MORE EFFECTIVE THAN 1 APPLICATION AT PREVENTING SUBSEQUENT CARIES-RELATED EXTRACTION, ROOT CANAL THERAPY OR DIRECT/INDIRECT RESTORATIONS DURING THE 1-5 YEAR FOLLOW-UP PERIOD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $155.1k | 6/16/25 | ||
| Not listed | $0 | 8/21/24 | ||
| Not listed | $0 | 8/21/24 | ||
| Not listed | $179.1k | 7/25/24 | ||
| Not listed | $179.1k | 7/25/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
4500005119S | The Bedford VA Research Corporation. Inc. | Project Grant R03DE032387 | $43.4k | 10/11/24 |